{
  "Variants Include": [
    {
      "Gene": "TP53",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "This variant causes a structural change in the protein, affecting its function."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Hereditary Myopathy",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line, cultured under standard conditions (37Â°C, 5% CO2)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by approximately 50% on day 7 after transfection of HEK293 cells with the mutant construct. Control cells transfected with wild-type TP53 showed normal protein levels."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed, each using a new batch of HEK293 cells."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate on the Western blot membrane to ensure technical reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "HEK293 cells transfected with a plasmid containing wild-type TP53 cDNA served as a positive control to confirm antibody specificity and overall assay performance."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "HEK293 cells transfected with an empty vector plasmid (no TP53 insert) served as a negative control to rule out background signal."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2",
        "Description": "Two previously validated pathogenic TP53 variants (c.XXX>Y and c.ZZZ>W) were included as positive validation controls."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1",
        "Description": "One previously validated benign TP53 variant (c.AAA>BBB) was included as a negative validation control."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by Tukey's post-hoc test was used to determine statistical significance between experimental groups.  p < 0.05 was considered statistically significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression level between 80% and 120% of the control group on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression level less than 80% or greater than 120% of the control group on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Western blot analysis for TP53 protein expression is a standard assay used in research and diagnostic settings to assess TP53 function."
      }
    }
  ]
}